BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD. Financials Beijing Bohui Innovation Biotechnology Group Co., Ltd.
Equities
300318
CNE000001QR4
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.38 CNY | +0.37% |
|
-4.95% | -13.78% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,261 | 3,341 | 9,770 | 8,095 | 4,779 | 5,097 |
| Enterprise Value (EV) 1 | 3,488 | 3,920 | 10,340 | 8,609 | 5,453 | 5,801 |
| P/E ratio | 46.9 x | 1,319 x | 1,300 x | -25.1 x | -61 x | -205 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 5.24 x | 5.32 x | 13.2 x | 11.3 x | 6 x | 4.88 x |
| EV / Revenue | 5.61 x | 6.24 x | 14 x | 12 x | 6.85 x | 5.55 x |
| EV / EBITDA | 30.2 x | 35.6 x | 89.8 x | -1,557 x | 912 x | 34.3 x |
| EV / FCF | 10.1 x | -49.2 x | 26 x | 41.6 x | -3.58 x | -107 x |
| FCF Yield | 9.86% | -2.03% | 3.85% | 2.4% | -27.9% | -0.94% |
| Price to Book | 2.78 x | 3.24 x | 7.52 x | 8.31 x | 3.43 x | 3.73 x |
| Nbr of stocks (in thousands) | 8,19,430 | 8,16,900 | 8,16,900 | 8,16,900 | 8,16,900 | 8,16,900 |
| Reference price 2 | 3.980 | 4.090 | 11.96 | 9.910 | 5.850 | 6.240 |
| Announcement Date | 22/04/19 | 23/04/20 | 26/04/21 | 27/04/22 | 25/04/23 | 25/04/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 622.1 | 628.3 | 738.7 | 714.7 | 795.9 | 1,045 |
| EBITDA 1 | 115.6 | 110.1 | 115.1 | -5.53 | 5.982 | 169.2 |
| EBIT 1 | 48.68 | 37.41 | 26.21 | -112 | -99.16 | 69.43 |
| Operating Margin | 7.83% | 5.95% | 3.55% | -15.67% | -12.46% | 6.64% |
| Earnings before Tax (EBT) 1 | 107 | 9.634 | 0.585 | -504.2 | -133.8 | 33.73 |
| Net income 1 | 69.44 | 2.543 | 7.504 | -322.2 | -78.33 | -24.93 |
| Net margin | 11.16% | 0.4% | 1.02% | -45.08% | -9.84% | -2.38% |
| EPS 2 | 0.0848 | 0.003100 | 0.009200 | -0.3944 | -0.0959 | -0.0305 |
| Free Cash Flow 1 | 343.7 | -79.71 | 398.3 | 207 | -1,523 | -54.37 |
| FCF margin | 55.26% | -12.69% | 53.92% | 28.96% | -191.39% | -5.2% |
| FCF Conversion (EBITDA) | 297.26% | - | 345.95% | - | - | - |
| FCF Conversion (Net income) | 495.04% | - | 5,308.51% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 22/04/19 | 23/04/20 | 26/04/21 | 27/04/22 | 25/04/23 | 25/04/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 226 | 579 | 569 | 513 | 674 | 703 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.956 x | 5.263 x | 4.946 x | -92.82 x | 112.7 x | 4.157 x |
| Free Cash Flow 1 | 344 | -79.7 | 398 | 207 | -1,523 | -54.4 |
| ROE (net income / shareholders' equity) | 5.42% | 0.18% | -0.61% | -42.7% | -8.47% | 0.67% |
| ROA (Net income/ Total Assets) | 1.12% | 0.86% | 0.51% | -1.89% | -1.63% | 1.11% |
| Assets 1 | 6,219 | 294 | 1,468 | 17,045 | 4,801 | -2,250 |
| Book Value Per Share 2 | 1.430 | 1.260 | 1.590 | 1.190 | 1.710 | 1.670 |
| Cash Flow per Share 2 | 0.1300 | 0.0400 | 0.0500 | 0.0500 | 0.1400 | 0.1300 |
| Capex 1 | 53.3 | 109 | 202 | 367 | 161 | 198 |
| Capex / Sales | 8.57% | 17.33% | 27.39% | 51.35% | 20.29% | 18.9% |
| Announcement Date | 22/04/19 | 23/04/20 | 26/04/21 | 27/04/22 | 25/04/23 | 25/04/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.78% | 61Cr | |
| -2.32% | 9.26TCr | |
| +3.68% | 4.14TCr | |
| -11.43% | 3.35TCr | |
| -19.34% | 1.46TCr | |
| -9.05% | 1.28TCr | |
| -11.34% | 1.16TCr | |
| -43.53% | 1.13TCr | |
| +3.75% | 896.84Cr | |
| -6.32% | 829.97Cr |
- Stock Market
- Equities
- 300318 Stock
- Financials Beijing Bohui Innovation Biotechnology Group Co., Ltd.